<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>7747020</identifier>
<setSpec>0375-0906</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>González Martínez, M</dc:author>
<dc:author>Marín López, E</dc:author>
<dc:description xml:lang="en">Serum tumors markers tests have five potential uses; the value of a given tests depends on its sensitivity and specificity. As a rule tumor markers have no use as screening tests except for alpha-fetoprotein in hepatocarcinoma which value has been established, for monitoring treatment and for detecting relapse. On the other hand the highest value for carcino-embryonic antigen tests lies on the early detection of colonic cancer relapse. Ca 19-9 assay has a high sensitivity and specificity in diagnosis of pancreatic cancer and a high predictive value in unresectable disease. Low serum Testosterone/dihydrotestosterone ratio is useful in diagnosis pancreatic carcinoma. There is no useful marker for diagnosis of gastric cancer.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:date>1993 Apr-Jun </dc:date>
<dc:title xml:lang="es">Aplicaciones clínicas de los marcadores tumorales séricos en gastroenterología.</dc:title>
<dc:title xml:lang="en">[The clinical applications of serum tumor markers in gastroenterology].</dc:title>
<dc:publisher>Revista de gastroenterologia de Mexico</dc:publisher>
</metadata>
</record>
</pubmed-document>
